About: Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2001 (uk) im Mai 2001 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2001 (ast) scientific article published on 01 May 2001 (en)
publication date	wds:Q73919544-E4E76875-DEB8-4ECA-943B-70BDC907CFF7
publication date	2001-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73919544-0D65493C-D6D5-48AD-A082-6C11AEFDBA9B
language of work or name	English
author name string	wds:Q73919544-208CC7AA-77DD-4EED-B69B-8035172544FF wds:Q73919544-29384C00-711F-4349-89AB-357FA5584E59 wds:Q73919544-29B394E1-8D65-4A4D-9920-D0CD8914E892 wds:Q73919544-30E68E1E-C7CE-47A1-A1F3-210BD1E1BE50 wds:Q73919544-74D69DD8-0AC0-446F-940E-6E9713B61474 wds:Q73919544-763AD7A5-D10D-464B-84A6-1DEA7481A3CE wds:Q73919544-9FAFD026-34E4-47B4-A786-5C16A0F4771D wds:Q73919544-CFD5BB4B-0EBE-4C30-A2C1-77D3C12D6CD0 wds:Q73919544-D2410F3B-6310-457D-981C-A2CF8656C6DC wds:Q73919544-FB65A5A9-588F-4D6B-8F15-61237D420EF1
author name string	J P Boissel I Durieu J Ninet L Pinede P Duhaut P Nony S Chabaud S Demolombe-Rague C Sanson Investigators of the "Durée Optimale du Traitement AntiVitamines K" (DOTAVK) Study
rdfs:label	Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis (en) Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis (nl)
skos:prefLabel	Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis (en) Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis (nl)
name	Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis (en) Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis (nl)
title	wds:Q73919544-387313D0-763D-46AD-9C36-674AF0702BCE
title	Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis (en)
page(s)	wds:Q73919544-E9C6AD65-3BE0-4AD2-AC50-30997763B743
page(s)	2453-2460
instance of	wds:Q73919544-F50D64DD-A5FA-4166-994A-3307AEE6FE1C
instance of	scholarly article
main subject	wds:Q73919544-23591480-2EF9-4344-ADD4-C43FEC596AD2 wds:Q73919544-440CD8DC-BC07-4D24-A600-924DC92DE659 wds:Q73919544-E85BDE88-1B2B-49F6-9BCD-3B6A98045930
main subject	deep vein thrombosis anticoagulant thrombosis
PubMed ID	wds:Q73919544-6C5D9AC3-3BC2-41D7-BCFE-EB59AD44F7F1
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11369685
PubMed ID	11369685
published in	wds:Q73919544-1545E784-7A1A-4CD0-B145-64AB57B1BBAB
published in	Circulation
issue	wds:Q73919544-9BEDAF75-38E7-4B2A-832C-C25A64ED4822
volume	wds:Q73919544-D5E6FE68-E670-4BF0-BEC3-3626979B3A39
issue	20
volume	103
DOI	wds:Q73919544-32C4A876-5862-4E02-A8C5-F31F133B180F
DOI	http://dx.doi.org/10.1161/01.CIR.103.20.2453
DOI	10.1161/01.CIR.103.20.2453
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73919544
is cites work of	Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials Unresolved issues in anticoagulant therapy Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran Review of venous thromboembolism and race: the generalizability of treatment guidelines for high-risk populations Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial Deep vein thrombosis Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism: The Present State of the Art The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism Epidemiology of venous thromboembolism The epidemiology of venous thromboembolism in the community: implications for prevention and management Recurrent venous thromboembolism: what is the risk and how to prevent it Treatment of DVT: how long is enough and how do you predict recurrence Sex differences in patients receiving anticoagulant therapy for venous thromboembolism Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians Duration of anticoagulation after cerebral venous sinus thrombosis The epidemiology of venous thromboembolism Guidance for the treatment of deep vein thrombosis and pulmonary embolism Treatment of venous thromboembolism: guidelines translated for the clinician Acute pulmonary embolism. Part 2: treatment Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated Effect of a combined education and eHealth programme on the control of oral anticoagulation patients (PORTALS study): a parallel cohort design in Dutch primary care Should symptomatic, isolated distal deep vein thrombosis be treated with anticoagulation? Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism Tumor-Specific D-Dimer Concentration Ranges and Influencing Factors: A Cross-Sectional Study Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software